Contriving a novel of CHB therapeutic vaccine based on IgV_CTLA-4 and L protein via immunoinformatics approach

References

• Alexopoulou, A., Vasilieva, L., & Karayiannis, P. (2020). New approaches to the treatment of chronic hepatitis B. Journal of Clinical Medicine, 9(10), 3187. https://doi.org/10.3390/jcm9103187
   PubMed Web of Science ®Google Scholar
• Almagro Armenteros, J. J., Tsirigos, K. D., Sønderby, C. K., Petersen, T. N., Winther, O., Brunak, S., von Heijne, G., & Nielsen, H. (2019). SignalP 5.0 improves signal peptide predictions using deep neural networks. Nature Biotechnology, 37(4), 420–423. https://doi.org/10.1038/s41587-019-0036-z
   PubMed Web of Science ®Google Scholar
• Baek, M., DiMaio, F., Anishchenko, I., Dauparas, J., Ovchinnikov, S., Lee, G. R., Wang, J., Cong, Q., Kinch, L. N., Schaeffer, R. D., Millán, C., Park, H., Adams, C., Glassman, C. R., DeGiovanni, A., Pereira, J. H., Rodrigues, A. V., van Dijk, A. A., Ebrecht, A. C., … Baker, D. (2021). Accurate prediction of protein structures and interactions using a three-track neural network. Science (New York, N.Y.), 373(6557), 871–876. https://doi.org/10.1126/science.abj8754
   PubMed Web of Science ®Google Scholar
• Baudi, I., Kawashima, K., & Isogawa, M. (2021). HBV-specific CD8+ T-Cell tolerance in the liver. Frontiers in Immunology, 12, 721975. https://doi.org/10.3389/fimmu.2021.721975
   PubMed Web of Science ®Google Scholar
• Betancourt, A. A., Delgado, C. A. G., Estévez, Z. C., Martínez, J. C., Ríos, G. V., Aureoles-Roselló, S. R. M., Zaldívar, R. A., Guzmán, M. A., Baile, N. F., Reyes, P. A. D., Ruano, L. O., Fernández, A. C., Lobaina-Matos, Y., Fernández, A. D., Madrazo, A. I. J., Martínez, M. I. A., Baños, M. L., Alvarez, N. P., Baldo, M. D., … Rubido, J. C. A. (2007). Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens. International Journal of Infectious Diseases: IJID: Official Publication of the International Society for Infectious Diseases, 11(5), 394–401. https://doi.org/10.1016/j.ijid.2006.09.010
   PubMed Web of Science ®Google Scholar
• Bhattacharya, M., Sharma, A. R., Ghosh, P., Lee, S. S., & Chakraborty, C. (2021). A next-generation vaccine candidate using alternative epitopes to protect against wuhan and all significant mutant variants of SARS-CoV-2: An immunoinformatics approach. Aging and Disease, 12(8), 2173–2195. https://doi.org/10.14336/AD.2021.0518
   PubMed Web of Science ®Google Scholar
• Bian, Y., Zhang, Z., Sun, Z., Zhao, J., Zhu, D., Wang, Y., Fu, S., Guo, J., Liu, L., Su, L., Wang, F.-S., Fu, Y.-X., & Peng, H. (2017). Vaccines targeting preS1 domain overcome immune tolerance in hepatitis B virus carrier mice. Hepatology (Baltimore, Md.), 66(4), 1067–1082. https://doi.org/10.1002/hep.29239
   PubMed Web of Science ®Google Scholar
• Cargill, T., & Barnes, E. (2021). Therapeutic vaccination for treatment of chronic hepatitis B. Clinical and Experimental Immunology, 205(2), 106–118. https://doi.org/10.1111/cei.13614
   PubMed Web of Science ®Google Scholar
• Cheng, Y., Zhu, Y. O., Becht, E., Aw, P., Chen, J., Poidinger, M., de Sessions, P. F., Hibberd, M. L., Bertoletti, A., Lim, S. G., & Newell, E. W. (2019). Multifactorial heterogeneity of virus-specific T cells and association with the progression of human chronic hepatitis B infection. Science Immunology, 4(32), eaau6905. https://doi.org/10.1126/sciimmunol.aau6905
   PubMed Web of Science ®Google Scholar
• Chinese Medical Association, Chinese Medical Journals Publishing House, Chinese Society of General Practice, Editorial Board of Chinese Journal of Ceneral Practitioners of Chinese Medical Association, Expert Group of Guidelines for Primary Care of Chronic Hepatitis B. (2021). Guideline for primary care of chronic hepatitis B (2020). Chinese Journal of General Practitioners, 20, 137–149. https://doi.org/10.3760/cma.j.cn114798-20201218-01262
   Google Scholar
• Christoffer, C., Chen, S., Bharadwaj, V., Aderinwale, T., Kumar, V., Hormati, M., & Kihara, D. (2021). LZerD webserver for pairwise and multiple protein-protein docking. Nucleic Acids Research, 49(W1), W359–W365. P https://doi.org/10.1093/nar/gkab336
   PubMed Web of Science ®Google Scholar
• Cornberg, M., Lok, A. S., Terrault, N. A., & Zoulim, F. (2020). Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference. Hepatology, 71(3), 1070–1092. https://doi.org/10.1002/hep.31030
   Web of Science ®Google Scholar
• David, C. C., & Jacobs, D. J. (2014). Principal component analysis: a method for determining the essential dynamics of proteins. Methods in Molecular Biology (Clifton, N.J.), 1084, 193–226. https://doi.org/10.1007/978-1-62703-658-0_11
   PubMedGoogle Scholar
• Dimitrov, I., Bangov, I., Flower, D. R., & Doytchinova, I. (2014). AllerTOP v.2-a server for in silico prediction of allergens. Journal of Molecular Modeling, 20(6), 2278. https://doi.org/10.1007/s00894-014-2278-5
   PubMed Web of Science ®Google Scholar
• Doytchinova, I. A., & Flower, D. R. (2007). VaxiJen: A server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics, 8(1), 4. https://doi.org/10.1186/1471-2105-8-4
   PubMed Web of Science ®Google Scholar
• Farmer, J., Kanwal, F., Nikulsin, N., Tsilimigras, M. C. B., & Jacobs, D. J. (2017). Statistical measures to quantify similarity between molecular dynamics simulation trajectories. Entropy, 19(12), 646. https://doi.org/10.3390/e19120646
   PubMed Web of Science ®Google Scholar
• Fitzmaurice, C., Allen, C., Barber, R. M., Barregard, L., Bhutta, Z. A., Brenner, H., Dicker, D. J., Chimed-Orchir, O., Dandona, R., Dandona, L., Fleming, T., Forouzanfar, M. H., Hancock, J., Hay, R. J., Hunter-Merrill, R., Huynh, C., Hosgood, H. D., Johnson, C. O., Jonas, J. B., … Naghavi, M. (2017). Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: A systematic analysis for the global burden of disease study. JAMA Oncology, 3(4), 524–548. https://doi.org/10.1001/jamaoncol.2016.5688
   PubMed Web of Science ®Google Scholar
• Fu, Y., Wu, S., Hu, Y., Chen, T., Zeng, Y., Liu, C., & Ou, Q. (2020). Mutational characterization of HBV reverse transcriptase gene and the genotype-phenotype correlation of antiviral resistance among Chinese chronic hepatitis B patients. Emerging Microbes & Infections, 9(1), 2381–2393. https://doi.org/10.1080/22221751.2020.1835446
   PubMed Web of Science ®Google Scholar
• Gaggar, A., Coeshott, C., Apelian, D., Rodell, T., Armstrong, B. R., Shen, G., Subramanian, G. M., & McHutchison, J. G. (2014). Safety, tolerability and immunogenicity of GS-4774, a hepatitis B virus-specific therapeutic vaccine, in healthy subjects: A randomized study. Vaccine, 32(39), 4925–4931. https://doi.org/10.1016/j.vaccine.2014.07.027
   PubMed Web of Science ®Google Scholar
• Gan, L., Jia, R., Zhou, L., Guo, J., & Fan, M. (2014). Fusion of CTLA-4 with HPV16 E7 and E6 enhanced the potency of therapeutic HPV DNA vaccine. PloS One, 9(9), e108892. https://doi.org/10.1371/journal.pone.0108892
   PubMed Web of Science ®Google Scholar
• Gehring, A. J., & Protzer, U. (2019). Targeting innate and adaptive immune responses to cure chronic HBV infection. Gastroenterology, 156(2), 325–337. https://doi.org/10.1053/j.gastro.2018.10.032
   PubMed Web of Science ®Google Scholar
• Grimm, F. A., Lehmler, H. J., He, X., Robertson, L. W., & Duffel, M. W. (2013). Sulfated metabolites of polychlorinated biphenyls are high-affinity ligands for the thyroid hormone transport protein transthyretin. Environmental Health Perspectives, 121(6), 657–662. https://doi.org/10.1289/ehp.1206198
   PubMed Web of Science ®Google Scholar
• Han, Q., Lan, P., Zhang, J., Zhang, C., & Tian, Z. (2013). Reversal of hepatitis B virus-induced systemic immune tolerance by intrinsic innate immune stimulation. Journal of Gastroenterology and Hepatology, 28, 132–137. https://doi.org/10.1111/jgh.12034
   PubMed Web of Science ®Google Scholar
• He, J., Huang, F., Zhang, J., Chen, Q., Zheng, Z., Zhou, Q., Chen, D., Li, J., & Chen, J. (2021). Vaccine design based on 16 epitopes of SARS CoV-2 spike protein. Journal of Medical Virology, 93(4), 2115–2131. https://doi.org/10.1002/jmv.26596
   PubMed Web of Science ®Google Scholar
• He, Y., Li, J., Mao, W., Zhang, D., Liu, M., Shan, X., Zhang, B., Zhu, C., Shen, J., Deng, Z., Wang, Z., Yu, W., Chen, Q., Guo, W., Su, P., Lv, R., Li, G., Li, G., Pei, B., … Du, D. (2018). HLA common and well-documented alleles in China. HLA, 92(4), 199–205. https://doi.org/10.1111/tan.13358
   PubMed Web of Science ®Google Scholar
• Huang, S. Y., & Zou, X. (2011). Statistical mechanics‐based method to extract atomic distance‐dependent potentials from protein structures. Proteins, 79(9), 2648–2661. https://doi.org/10.1002/prot.23086
   PubMed Web of Science ®Google Scholar
• Jespersen, M. C., Peters, B., Nielsen, M., & Marcatili, P. (2017). BepiPred-2.0: Improving sequence-based B-cell epitope prediction using conformational epitopes. Nucleic Acids Research, 45(W1), W24–W29. https://doi.org/10.1093/nar/gkx346
   PubMed Web of Science ®Google Scholar
• Jia, R., Guo, J. H., & Fan, M. W. (2012). The effect of antigen size on the immunogenicity of antigen presenting cell targeted DNA vaccine. International Immunopharmacology, 12(1), 21–25. https://doi.org/10.1016/j.intimp.2011.08.016
   PubMed Web of Science ®Google Scholar
• Jiang, X., Chang, L., Yan, Y., & Wang, L. (2021). Paradoxical HBsAg and anti-HBs coexistence among chronic HBV infections: Causes and consequences. International Journal of Biological Sciences, 17(4), 1125–1137. https://doi.org/10.7150/ijbs.55724
   PubMed Web of Science ®Google Scholar
• Jin, S., Zou, H., Zhen, J., Wang, D., He, L., & Deng, Z. (2017). Study of polymorphisms of HLA class I (-A, -B, -C) and class II (DRB1, DQA1, DQB1, DPA1, DPB1) genes among ethnic Hans from Southern China. Zhonghua yi Xue yi Chuan Xue za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics, 34(1), 110–114. https://doi.org/10.3760/cma.j.issn.1003-9406.2017.01.026
   PubMedGoogle Scholar
• Karimi, A., Alilou, S., & Mirzaei, H. R. (2021). Adverse events following administration of anti-CTLA4 antibody ipilimumab. Frontiers in Oncology, 11, 624780. https://doi.org/10.3389/fonc.2021.624780
   PubMed Web of Science ®Google Scholar
• Krawczyk, A., Ludwig, C., Jochum, C., Fiedler, M., Heinemann, F. M., Shouval, D., Roggendorf, M., Roggendorf, H., & Lindemann, M. (2014). Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccine. Vaccine, 32(39), 5077–5082. https://doi.org/10.1016/j.vaccine.2014.06.076
   PubMed Web of Science ®Google Scholar
• Li, J., Bao, M., Ge, J., Ren, S., Zhou, T., Qi, F., Pu, X., & Dou, J. (2017). Research progress of therapeutic vaccines for treating chronic hepatitis B. Human Vaccines & Immunotherapeutics, 13(5), 986–997. https://doi.org/10.1080/21645515.2016.1276125
   PubMed Web of Science ®Google Scholar
• Li, Y., Zhu, Y., Sha, T., Chen, Z., Yu, M., Zhang, F., & Ding, J. (2021). A multi-epitope chitosan nanoparticles vaccine of canine against Echinococcus granulosus. Journal of Biomedical Nanotechnology, 17(5), 910–920. https://doi.org/10.1166/jbn.2021.3065
   PubMed Web of Science ®Google Scholar
• Lin, C. L., & Kao, J. H. (2015). Hepatitis B virus genotypes and variants. Cold Spring Harbor Perspectives in Medicine, 5(5), a021436. https://doi.org/10.1101/cshperspect.a021436
   PubMed Web of Science ®Google Scholar
• Liu, J., & Liu, M. (2019). Progress and challenges in achieving the WHO goal on ‘Elimination of Hepatitis B by 2030’ in China. Zhonghua Liu Xing Bing Xue za Zhi = Zhonghua Liuxingbingxue Zazhi, 40(6), 605–609. https://doi.org/10.3760/cma.j.issn.0254-6450.2019.06.001
   PubMedGoogle Scholar
• Liu, R., Li, X., Huang, Z., Zhao, D., Ganesh, B. S., Lai, G., Pandak, W. M., Hylemon, P. B., Bajaj, J. S., Sanyal, A. J., & Zhou, H. (2018). C/EBP homologous protein-induced loss of intestinal epithelial stemness contributes to bile duct ligation-induced cholestatic liver injury in mice. Hepatology (Baltimore, Md.), 67(4), 1441–1457. https://doi.org/10.1002/hep.29540
   PubMed Web of Science ®Google Scholar
• Maini, M. K., & Burton, A. R. (2019). Restoring, releasing or replacing adaptive immunity in chronic hepatitis B. Nature Reviews. Gastroenterology & Hepatology, 16(11), 662–675. https://doi.org/10.1038/s41575-019-0196-9
   PubMed Web of Science ®Google Scholar
• Megahed, F. A. K., Zhou, X., & Sun, P. (2020). The interactions between HBV and the innate immunity of hepatocytes. Viruses, 12(3), 285. https://doi.org/10.3390/v12030285
   PubMed Web of Science ®Google Scholar
• Melenhorst, J. J., Chen, G. M., Wang, M., Porter, D. L., Chen, C., Collins, M. A., Gao, P., Bandyopadhyay, S., Sun, H., Zhao, Z., Lundh, S., Pruteanu-Malinici, I., Nobles, C. L., Maji, S., Frey, N. V., Gill, S. I., Loren, A. W., Tian, L., Kulikovskaya, I., … June, C. H. (2022). Decade-long leukaemia remissions with persistence of CD4+ CAR T cells. Nature, 602(7897), 503–509. https://doi.org/10.1038/s41586-021-04390-6
   PubMed Web of Science ®Google Scholar
• Ott, J. J., Horn, J., Krause, G., & Mikolajczyk, R. T. (2017). Time trends of chronic HBV infection over prior decades – A global analysis. Journal of Hepatology, 66(1), 48–54. https://doi.org/10.1016/j.jhep.2016.08.013
   PubMed Web of Science ®Google Scholar
• Pimpin, L., Cortez-Pinto, H., Negro, F., Corbould, E., Lazarus, J. V., Webber, L., & Sheron, N. (2018). Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies. Journal of Hepatology, 69(3), 718–735. https://doi.org/10.1016/j.jhep.2018.05.011
   PubMed Web of Science ®Google Scholar
• Polaris Observatory Collaborators. (2018). Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: A modelling study. The Lancet. Gastroenterology & Hepatology, 3(6), 383–403. https://doi.org/10.1016/S2468-1253(18)30056-6
   PubMed Web of Science ®Google Scholar
• Rapin, N., Lund, O., Bernaschi, M., & Castiglione, F. (2010). Computational immunology meets bioinformatics: The use of prediction tools for molecular binding in the simulation of the immune system. PLoS One,.5(4), e9862. https://doi.org/10.1371/journal.pone.0009862
   PubMed Web of Science ®Google Scholar
• Ru, Z., Yu, M., Zhu, Y., Chen, Z., Zhang, F., Zhang, Z., & Ding, J. (2022). Immmunoinformatics‐based design of a multi‐epitope vaccine with CTLA‐4 extracellular domain to combat Helicobacter pylori. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 36(4), e22252. https://doi.org/10.1096/fj.202101538RR
   PubMed Web of Science ®Google Scholar
• Sargsyan, K., Grauffel, C., & Lim, C. (2017). How molecular size impacts RMSD applications in molecular dynamics simulations. Journal of Chemical Theory and Computation, 13(4), 1518–1524. https://doi.org/10.1021/acs.jctc.7b00028
   PubMed Web of Science ®Google Scholar
• Sarin, S. K., Kumar, M., Eslam, M., George, J., Al Mahtab, M., Akbar, S. M. F., Jia, J., Tian, Q., Aggarwal, R., Muljono, D. H., Omata, M., Ooka, Y., Han, K.-H., Lee, H. W., Jafri, W., Butt, A. S., Chong, C. H., Lim, S. G., Pwu, R.-F., & Chen, D.-S. (2020). Liver diseases in the Asia-Pacific region: A Lancet Gastroenterology & Hepatology Commission. The Lancet. Gastroenterology & Hepatology, 5(2), 167–228. https://doi.org/10.1016/S2468-1253(19)30342-5
   PubMed Web of Science ®Google Scholar
• Shouval, D., Roggendorf, H., & Roggendorf, M. (2015). Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S vaccine. Medical Microbiology and Immunology, 204(1), 57–68. https://doi.org/10.1007/s00430-014-0374-x
   PubMed Web of Science ®Google Scholar
• Song, Y., Ma, C., Lv, H., Zhu, C., Nie, X., Wang, M., Liu, Y., Zhang, P. (2007). HLA allele polymorphism in northern Hans of China. Journal of Shandong University (Health Science), 45, 546–553. https://doi.org/10.3969/j.issn.1671-7554.2007.06.002
   Google Scholar
• Tseng, T. C., & Kao, J. H. (2017). Elimination of hepatitis B: Is it a mission possible? BMC Medicine, 15(1), 53. https://doi.org/10.1186/s12916-017-0820-x
   PubMedGoogle Scholar
• Venkatraman, V., Yang, Y. D., Sael, L., & Kihara, D. (2009). Protein-protein docking using region-based 3D Zernike descriptors. BMC Bioinformatics, 10, 407. https://doi.org/10.1186/1471-2105-10-407
   PubMed Web of Science ®Google Scholar
• Wang, P., Sidney, J., Dow, C., Mothé, B., Sette, A., & Peters, B. (2008). A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach. PLoS Computational Biology, 4(4), e1000048. https://doi.org/10.1371/journal.pcbi.1000048
   PubMed Web of Science ®Google Scholar
• Waterhouse, A., Bertoni, M., Bienert, S., Studer, G., Tauriello, G., Gumienny, R., Heer, F. T., de Beer, T. A. P., Rempfer, C., Bordoli, L., Lepore, R., & Schwede, T. (2018). SWISS-MODEL: Homology modelling of protein structures and complexes. Nucleic Acids Research, 46(W1), W296–W303. https://doi.org/10.1093/nar/gky427
   PubMed Web of Science ®Google Scholar
• Wei, L., Zhao, T., Zhang, J., Mao, Q., Gong, G., Sun, Y., Chen, Y., Wang, M., Tan, D., Gong, Z., Li, B., Niu, J., Li, S., Gong, H., Zou, L., Zhou, W., Jia, Z., Tang, Y., Fei, L., … Wu, Y. (2022). Efficacy and safety of a nanoparticle therapeutic vaccine in patients with chronic hepatitis B: A randomized clinical trial. Hepatology (Baltimore, Md.), 75(1), 182–195. https://doi.org/10.1002/hep.32109
   PubMed Web of Science ®Google Scholar
• Wilkins, M. R., Gasteiger, E., Bairoch, A., Sanchez, J. C., Williams, K. L., Appel, R. D., & Hochstrasser, D. F. (1999). Protein identification and analysis tools in the ExPASy server. Methods in Molecular Biology (Clifton, N.J.), 112, 531–552. https://doi.org/10.1385/1-59259-584-7:531
   PubMedGoogle Scholar
• Xu, D.-Z., Zhao, K., Guo, L.-M., Li, L.-J., Xie, Q., Ren, H., Zhang, J.-M., Xu, M., Wang, H.-F., Huang, W.-X., Bai, X.-F., Niu, J.-Q., Liu, P., Chen, X.-Y., Shen, X.-L., Yuan, Z.-H., Wang, X.-Y., & Wen, Y.-M. (2008). A randomized controlled phase IIb trial of antigen-antibody immunogenic complex therapeutic vaccine in chronic hepatitis B patients. PloS One,.3(7), e2565. https://doi.org/10.1371/journal.pone.0002565
   PubMed Web of Science ®Google Scholar
• Yin, Y., Wu, C., Song, J., Wang, J., Zhang, E., Liu, H., Yang, D., Chen, X., Lu, M., & Xu, Y. (2011). DNA immunization with fusion of CTLA-4 to hepatitis B virus (HBV) core protein enhanced Th2 type responses and cleared HBV with an accelerated kinetic. PLoS One,.6(7), e22524. https://doi.org/10.1371/journal.pone.0022524
   PubMed Web of Science ®Google Scholar
• Yu, M., Zhu, Y., Li, Y., Chen, Z., Li, Z., Wang, J., Li, Z., Zhang, F., & Ding, J. (2022). Design of a recombinant multivalent epitope vaccine based on SARS-CoV-2 and its variants in Immunoinformatics approach. Frontiers in Immunology, 13, 884433. https://doi.org/10.3389/fimmu.2022.884433
   PubMed Web of Science ®Google Scholar
• Yu, M., Zhu, Y., Li, Y., Chen, Z., Sha, T., Li, Z., Zhang, F., & Ding, J. (2021). Design of a Novel Multi-Epitope Vaccine Against Echinococcus granulosus in Immunoinformatics. Frontiers in Immunology, 12, 668492. https://doi.org/10.3389/fimmu.2021.668492
   PubMed Web of Science ®Google Scholar
• Zhang, L., & Bansal, M. B. (2020). Role of Kupffer cells in driving hepatic inflammation and fibrosis in HIV infection. Frontiers in Immunology, 11, 1086. https://doi.org/10.3389/fimmu.2020.01086
   PubMed Web of Science ®Google Scholar
• Zhang, T.-Y., Guo, X.-R., Wu, Y.-T., Kang, X.-Z., Zheng, Q.-B., Qi, R.-Y., Chen, B.-B., Lan, Y., Wei, M., Wang, S.-J., Xiong, H.-L., Cao, J.-L., Zhang, B.-H., Qiao, X.-Y., Huang, X.-F., Wang, Y.-B., Fang, M.-J., Zhang, Y.-L., Cheng, T., … Xia, N.-S. (2020). A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in mice. Gut, 69(2), 343–354. https://doi.org/10.1136/gutjnl-2018-317725
   PubMed Web of Science ®Google Scholar
• Zhou, H., & Skolnick, J. (2011). GOAP: A generalized orientation-dependent, all-atom statistical potential for protein structure prediction. Biophysical Journal, 101(8), 2043–2052. https://doi.org/10.1016/j.bpj.2011.09.012
   PubMed Web of Science ®Google Scholar
• Zhou, H., & Zhou, Y. (2002). Distance‐scaled, finite ideal‐gas reference state improves structure‐derived potentials of mean force for structure selection and stability prediction. Protein Science : A Publication of the Protein Society, 11(11), 2714–2726. https://doi.org/10.1110/ps.0217002
   PubMed Web of Science ®Google Scholar